| Name | 4-bromo-2-piperazin-1-yl-1,3-thiazole |
|---|---|
| Synonyms |
1-(4-bromothiazol-2-yl)piperazine
1-(4-Bromo-1,3-thiazol-2-yl)piperazine 4-bromo-2-(piperazin-1-yl)thiazole Piperazine, 1-(4-bromo-2-thiazolyl)- |
| Density | 1.6±0.1 g/cm3 |
|---|---|
| Boiling Point | 350.1±52.0 °C at 760 mmHg |
| Molecular Formula | C7H10BrN3S |
| Molecular Weight | 248.143 |
| Flash Point | 165.5±30.7 °C |
| Exact Mass | 246.977875 |
| PSA | 56.40000 |
| LogP | 0.57 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.605 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2934100090 |
|
~55%
668484-59-1 |
| Literature: THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; THE UNIVERSITY OF MASSACHUSETTS; MARUGAN, Juan Jose; XIAO, Jingbo; TITUS, Steven A.; SOUTHALL, Noel; ZHENG, Wei; ANDROPHY, Elliot J.; CHERRY, Jonathan Patent: WO2011/130515 A1, 2011 ; Location in patent: Page/Page column 24 ; |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |